The GLP-1 weight loss medication market faces challenges like high costs and insurance limitations. Shortages of these drugs affect both obesity and diabetes patients, highlighting the need for improved accessibility. GSK plc is a key player in weight loss drugs, with successful financial performance and a promising pipeline.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay